Literature DB >> 29025988

Advanced Methods for Radiolabeling Multimodality Nanomedicines for SPECT/MRI and PET/MRI.

Jennifer Lamb1, Jason P Holland2.   

Abstract

The advent of hybrid cameras that combine MRI with either SPECT or PET has stimulated growing interest in developing multimodality imaging probes. Countless options are available for fusing magnetically active species with positron- or γ-ray-emitting radionuclides. The initial problem is one of choice: which chemical systems are a suitable basis for developing hybrid imaging agents? Any attempt to answer this question must also address how the physical, chemical, and biologic properties of a unified imaging agent can be tailored to ensure that optimum specificity and contrast are achieved simultaneously for both imaging modalities. Nanoparticles have emerged as attractive platforms for building multimodality radiotracers for SPECT/MRI and PET/MRI. A wide variety of nanoparticle constructs have been utilized as radiotracers, but irrespective of the particle class, radiolabeling remains a key step. Classic methods for radiolabeling nanoparticles involve functionalization of the particle surface, core, or coating. These modifications typically rely on using traditional metal ion chelate or prosthetic group chemistries. Though seemingly innocuous, appending nanoparticles with these radiolabeling handles can have dramatic effects on important properties such as particle size, charge, and solubility. In turn, alterations in the chemical and physical properties of the nanoparticle often have a negative impact on their pharmacologic profile. A central challenge in radiolabeling nanoparticles is to identify alternative chemical methods that facilitate the introduction of a radioactive nuclide without detrimental effects on the pharmacokinetic and toxicologic properties of the construct. Efforts to solve this challenge have generated a range of innovative chelate-free radiolabeling methods that exploit intrinsic chemical features of nanoparticles. Here, the chemistry of 9 mechanistically distinct methods for radiolabeling nanoparticles is presented. This discourse illustrates the evolution of nanoparticle radiochemistry from classic approaches to modern chelate-free or intrinsic methods.
© 2018 by the Society of Nuclear Medicine and Molecular Imaging.

Entities:  

Keywords:  PET/MRI; cation exchange; chelate-free; chemisorption; doping; intrinsic radiolabeling; isotopic exchange; nanoparticles

Mesh:

Year:  2017        PMID: 29025988     DOI: 10.2967/jnumed.116.187419

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  25 in total

Review 1.  Radionuclide-Activated Nanomaterials and Their Biomedical Applications.

Authors:  Carolina A Ferreira; Dalong Ni; Zachary T Rosenkrans; Weibo Cai
Journal:  Angew Chem Int Ed Engl       Date:  2019-07-08       Impact factor: 15.336

2.  Dual Encapsulated Dacarbazine and Zinc Phthalocyanine Polymeric Nanoparticle for Photodynamic Therapy of Melanoma.

Authors:  Sara Rhaissa Rezende do Reis; Edward Helal-Neto; Aline Oliveira da Silva de Barros; Suyene Rocha Pinto; Filipe Leal Portilho; Luciana Betzler de Oliveira Siqueira; Luciana Magalhães Rebelo Alencar; Si Amar Dahoumane; Frank Alexis; Eduardo Ricci-Junior; Ralph Santos-Oliveira
Journal:  Pharm Res       Date:  2021-02-18       Impact factor: 4.200

3.  Iron oxide nanoparticulate system as a cornerstone in the effective delivery of Tc-99 m radionuclide: a potential molecular imaging probe for tumor diagnosis.

Authors:  Mohamed M Swidan; Omnya M Khowessah; Mohamed Abd El-Motaleb; Ahmed Abd El-Bary; Mohamed T El-Kolaly; Tamer M Sakr
Journal:  Daru       Date:  2019-01-31       Impact factor: 3.117

Review 4.  Magnetic Nanoparticles in Cancer Therapy and Diagnosis.

Authors:  Ali Farzin; Seyed Alireza Etesami; Jacob Quint; Adnan Memic; Ali Tamayol
Journal:  Adv Healthc Mater       Date:  2020-03-20       Impact factor: 9.933

5.  Biodistribution and PET imaging of 89-zirconium labeled cerium oxide nanoparticles synthesized with several surface coatings.

Authors:  Philip Reed McDonagh; Gobalakrishnan Sundaresan; Likun Yang; Minghao Sun; Ross Mikkelsen; Jamal Zweit
Journal:  Nanomedicine       Date:  2018-04-08       Impact factor: 5.307

6.  A Chelate-Free Nano-Platform for Incorporation of Diagnostic and Therapeutic Isotopes.

Authors:  Yaser H Gholami; Lee Josephson; Eman A Akam; Peter Caravan; Moses Q Wilks; Xiang-Zuo Pan; Richard Maschmeyer; Aleksandra Kolnick; Georges El Fakhri; Marc D Normandin; Zdenka Kuncic; Hushan Yuan
Journal:  Int J Nanomedicine       Date:  2020-01-07

7.  A Radio-Nano-Platform for T1/T2 Dual-Mode PET-MR Imaging.

Authors:  Yaser Hadi Gholami; Hushan Yuan; Moses Q Wilks; Richard Maschmeyer; Marc D Normandin; Lee Josephson; Georges El Fakhri; Zdenka Kuncic
Journal:  Int J Nanomedicine       Date:  2020-02-24

8.  A method to improve quantitative radiotracing-based analysis of the in vivo biodistribution of drug carriers.

Authors:  Nikša Roki; Melani Solomon; Lou Casta; Jessica Bowers; Robert C Getts; Silvia Muro
Journal:  Bioeng Transl Med       Date:  2021-02-13

Review 9.  Nanoparticles Functionalised with Re(I) Tricarbonyl Complexes for Cancer Theranostics.

Authors:  Marcus Mkhatshwa; Joshua Mamolatelo Moremi; Katlego Makgopa; Amanda-Lee Ezra Manicum
Journal:  Int J Mol Sci       Date:  2021-06-18       Impact factor: 5.923

Review 10.  Degradation of Drug Delivery Nanocarriers and Payload Release: A Review of Physical Methods for Tracing Nanocarrier Biological Fate.

Authors:  Patrick M Perrigue; Richard A Murray; Angelika Mielcarek; Agata Henschke; Sergio E Moya
Journal:  Pharmaceutics       Date:  2021-05-21       Impact factor: 6.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.